| Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals C Manisty, AD Otter, TA Treibel, Á McKnight, DM Altmann, T Brooks, ... The Lancet 397 (10279), 1057-1058, 2021 | 432 | 2021 |
| Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose CJ Reynolds, C Pade, JM Gibbons, DK Butler, AD Otter, K Menacho, ... Science 372 (6549), 1418-1423, 2021 | 335 | 2021 |
| Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 L Swadling, MO Diniz, NM Schmidt, OE Amin, A Chandran, E Shaw, ... Nature 601 (7891), 110-117, 2022 | 328 | 2022 |
| What policy makers need to know about COVID-19 protective immunity DM Altmann, DC Douek, RJ Boyton The Lancet 395 (10236), 1527-1529, 2020 | 315 | 2020 |
| Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota … ES Chambers, CS Byrne, DJ Morrison, KG Murphy, T Preston, C Tedford, ... Gut 68 (8), 1430-1438, 2019 | 311 | 2019 |
| Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure CJ Reynolds, C Pade, JM Gibbons, AD Otter, KM Lin, D Muñoz Sandoval, ... Science 377 (6603), eabq1841, 2022 | 284 | 2022 |
| SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection DM Altmann, RJ Boyton Science immunology 5 (49), eabd6160, 2020 | 277 | 2020 |
| Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression JD Campbell, KF Buckland, SJ McMillan, J Kearley, WLG Oldfield, ... Journal of Experimental Medicine 206 (7), 1535-1547, 2009 | 252 | 2009 |
| Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2 I McDonald, SM Murray, CJ Reynolds, DM Altmann, RJ Boyton npj Vaccines 6 (1), 74, 2021 | 235 | 2021 |
| Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease RJ Boyton, DM Altmann Clinical & Experimental Immunology 149 (1), 1-8, 2007 | 221 | 2007 |
| Immunity to SARS-CoV-2 variants of concern DM Altmann, RJ Boyton, R Beale Science 371 (6534), 1103-1104, 2021 | 204 | 2021 |
| Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection CJ Reynolds, L Swadling, JM Gibbons, C Pade, MP Jensen, MO Diniz, ... Science immunology 5 (54), eabf3698, 2020 | 195 | 2020 |
| Pulmonary defences to acute respiratory infection RJ Boyton, PJ Openshaw British medical bulletin 61 (1), 1-12, 2002 | 177 | 2002 |
| COVID-19 vaccination: The road ahead DM Altmann, RJ Boyton Science 375 (6585), 1127-1132, 2022 | 171 | 2022 |
| COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study JL Alexander, NA Kennedy, H Ibraheim, S Anandabaskaran, A Saifuddin, ... The lancet Gastroenterology & hepatology 7 (4), 342-352, 2022 | 127 | 2022 |
| Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers LA Dos Santos, PG de Góis Filho, AMF Silva, JVG Santos, DS Santos, ... Journal of Infection 82 (3), 399-406, 2021 | 119 | 2021 |
| The immunology of long COVID DM Altmann, EM Whettlock, S Liu, DJ Arachchillage, RJ Boyton Nature Reviews Immunology 23 (10), 618-634, 2023 | 114 | 2023 |
| Is selection for TCR affinity a factor in cytokine polarization? RJ Boyton, DM Altmann Trends in immunology 23 (11), 526-529, 2002 | 114 | 2002 |
| Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants CJ Reynolds, JM Gibbons, C Pade, KM Lin, DM Sandoval, F Pieper, ... Science 375 (6577), 183-192, 2022 | 103 | 2022 |
| Antibiotic therapy and outcome from immune-checkpoint inhibitors DJ Pinato, D Gramenitskaya, DM Altmann, RJ Boyton, BH Mullish, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 98 | 2019 |
